Why the study?
Does stent-based delivery of sirolimus reduce neointimal formation in a porcine coronary model?
Does stent-based delivery of sirolimus reduce neointimal formation in a porcine coronary model?
Answers are grounded in this paper and cite their sources.
Stent-based delivery of sirolimus via a nonerodable polymer matrix is feasible and effectively reduces neointimal hyperplasia in a preclinical porcine model.
Stent-based delivery of SRL via a nonerodable polymer matrix is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: